CVS HEALTH Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CVS HEALTH Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q2 2024.
  • CVS HEALTH Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $1.77B, a 6.89% decline year-over-year.
  • CVS HEALTH Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $7.19B, a 142% increase year-over-year.
  • CVS HEALTH Corp annual Net Income (Loss) Attributable to Parent for 2023 was $8.34B, a 93.6% increase from 2022.
  • CVS HEALTH Corp annual Net Income (Loss) Attributable to Parent for 2022 was $4.31B, a 46.1% decline from 2021.
  • CVS HEALTH Corp annual Net Income (Loss) Attributable to Parent for 2021 was $8B, a 11.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.19B $1.77B -$131M -6.89% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $7.32B $1.11B -$1.02B -47.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $8.34B $2.05B -$288M -12.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 $8.63B $2.26B +$5.67B Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $2.97B $1.9B -$1.13B -37.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $4.09B $2.14B -$218M -9.26% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $4.31B $2.33B +$937M +67.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 $3.37B -$3.41B -$5B -313% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $8.38B $3.03B +$246M +8.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $8.13B $2.35B +$131M +5.89% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $8B $1.4B +$424M +43.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 $7.58B $1.6B +$374M +30.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $7.2B $2.78B -$192M -6.45% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $7.4B $2.22B +$216M +10.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $7.18B $973M -$774M -44.3% Oct 1, 2020 Dec 31, 2020 8-K 2023-05-25
Q3 2020 $7.95B $1.22B -$306M -20% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $8.26B $2.98B +$1.04B +53.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $7.22B $2.01B +$586M +41.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $6.63B $1.75B +$2.17B Oct 1, 2019 Dec 31, 2019 10-K 2020-02-18
Q3 2019 $4.47B $1.53B +$140M +10.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $4.33B $1.94B +$4.5B Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$171M $1.42B +$423M +42.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$594M -$419M -$3.71B -113% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 $3.11B $1.39B +$105M +8.17% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-18
Q2 2018 $3.01B -$2.56B -$3.66B -333% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-18
Q1 2018 $6.67B $998M +$46M +4.83% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-18
Q4 2017 $6.62B $3.29B +$1.58B +92.6% Oct 1, 2017 Dec 31, 2017 8-K 2019-08-08
Q3 2017 $5.04B $1.29B -$255M -16.6% Jul 1, 2017 Sep 30, 2017 8-K 2019-08-08
Q2 2017 $5.3B $1.1B +$174M +18.8% Apr 1, 2017 Jun 30, 2017 8-K 2019-08-08
Q1 2017 $5.12B $952M -$194M -16.9% Jan 1, 2017 Mar 31, 2017 8-K 2019-08-08
Q4 2016 $5.32B $1.71B +$209M +14% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-14
Q3 2016 $5.11B $1.54B +$294M +23.6% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-14
Q2 2016 $4.81B $924M -$348M -27.4% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-14
Q1 2016 $5.16B $1.15B -$75M -6.14% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-14
Q4 2015 $5.24B $1.5B Oct 1, 2015 Dec 31, 2015 10-K 2017-02-09
Q3 2015 $1.25B Jul 1, 2015 Sep 30, 2015 10-K 2017-02-09
Q2 2015 $1.27B Apr 1, 2015 Jun 30, 2015 10-K 2017-02-09
Q1 2015 $1.22B Jan 1, 2015 Mar 31, 2015 10-K 2017-02-09
Q2 2011 $3.36B $816M -$5M -0.61% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-04
Q1 2011 $3.37B $713M -$58M -7.52% Jan 1, 2011 Mar 31, 2011 10-Q 2011-05-05
Q4 2010 $3.43B $1.03B Oct 1, 2010 Dec 31, 2010 10-K 2011-02-18
Q3 2010 $809M Jul 1, 2010 Sep 30, 2010 10-K 2011-02-18
Q2 2010 $821M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $771M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.